Page last updated: 2024-10-24

chloroquine and Graves Ophthalmopathy

chloroquine has been researched along with Graves Ophthalmopathy in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guo, Y1
Li, H1
Chen, X1
Yang, H1
Guan, H1
He, X1
Chen, Y1
Pokharel, S1
Xiao, H1
Li, Y1

Other Studies

1 other study available for chloroquine and Graves Ophthalmopathy

ArticleYear
Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
    The Journal of clinical endocrinology and metabolism, 2020, 06-01, Volume: 105, Issue:6

    Topics: Adipogenesis; Adult; Aged; Antimalarials; Autophagy; Case-Control Studies; Cell Differentiation; Cel

2020